ERBB2 and neoplasm: Although still partial, these results outline the capacity of the treatment presented herein at achieving major tumor reduction, and eventually disease eradication in patients with previously untreated advanced inoperable and/or metastatic breast carcinoma expressing or not the ERs, either without or with HER2 overexpression.